Philippe Chouvarine
Overview
Explore the profile of Philippe Chouvarine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
718
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Legchenko E, Chouvarine P, Hysko K, Qadri F, Wesolowski R, Specker E, et al.
Am J Respir Cell Mol Biol
. 2025 Feb;
PMID: 39899532
Inhaled pharmacotherapies are promising treatment options for patients with pulmonary arterial hypertension (PAH) as they minimize extrapulmonary adverse effects. Recently, we developed a highly specific inhibitor (TPHi) of the serotonin...
2.
Hansmann G, Chouvarine P, Diekmann F, Giera M, Ralser M, Mulleder M, et al.
Nat Cardiovasc Res
. 2024 Aug;
1(6):568-576.
PMID: 39195868
Here we report application of human umbilical cord mesenchymal stem cell (HUCMSC)-derived therapy for pulmonary arterial hypertension (PAH). A 3-year-old female presented with heritable PAH associated with hereditary hemorrhagic telangiectasia...
3.
Legchenko E, Chouvarine P, Qadri F, Specker E, Nazare M, Wesolowski R, et al.
JACC Basic Transl Sci
. 2024 Aug;
9(7):890-902.
PMID: 39170954
The serotonin pathway has long been proposed as a promising target for pulmonary arterial hypertension (PAH)-a progressive and uncurable disease. We developed a highly specific inhibitor of the serotonin synthesizing...
4.
Hasan H, Chouvarine P, Hansmann G
JACC Adv
. 2024 Jun;
1(3):100055.
PMID: 38938394
No abstract available.
5.
Hansmann G, Chouvarine P
J Heart Lung Transplant
. 2024 Jan;
43(5):861-862.
PMID: 38284965
No abstract available.
6.
Beder T, Hansen B, Hartmann A, Zimmermann J, Amelunxen E, Wolgast N, et al.
Hemasphere
. 2023 Aug;
7(9):e939.
PMID: 37645423
Current classifications (World Health Organization-HAEM5/ICC) define up to 26 molecular B-cell precursor acute lymphoblastic leukemia (BCP-ALL) disease subtypes by genomic driver aberrations and corresponding gene expression signatures. Identification of driver...
7.
Jack T, Carlens J, Diekmann F, Hasan H, Chouvarine P, Schwerk N, et al.
Front Cardiovasc Med
. 2023 Jul;
10:1193326.
PMID: 37441704
Background: Bilateral lung transplantation (LuTx) remains the only established treatment for children with end-stage pulmonary arterial hypertension (PAH). Although PAH is the second most common indication for LuTx, little is...
8.
Chouvarine P, Hysko K, Chan S, Oliveira P, Maron B, Kourembanas S, et al.
Pulm Circ
. 2023 Jan;
13(1):e12175.
PMID: 36628260
No abstract available.
9.
Schweintzger S, Kurath-Koller S, Burmas A, Grangl G, Fandl A, Noessler N, et al.
Front Cardiovasc Med
. 2022 Aug;
9:950765.
PMID: 35911557
Background: An accurate assessment of the right and left ventricle and their interaction is important in pediatric pulmonary hypertension (PH). Our objective was to provide normal reference values for the...
10.
Hasan H, Chouvarine P, Diekmann F, Diedrich N, Koestenberger M, Hansmann G
Eur J Clin Invest
. 2022 Jul;
52(11):e13835.
PMID: 35844040
Objectives: In 2019, the European Paediatric Pulmonary Vascular Disease Network (EPPVDN) developed a PH risk score to assess the risk and severity of pulmonary hypertension (PH) in children and young...